Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

84 results
  1. ... Alternative bimonthly cycles of doxorubicin, cyclophosphamide, and etoposide, cisplatin with hematopoietic growth factor support in patients with carcinoma of unknown primary ...
  2. ... Malnutrition Medicines including amphotericin, antibodies targeting the epidermal growth factor (EGF) receptor, cisplatin, cyclosporine, diuretics, proton pump inhibitors, tacrolimus, and aminoglycoside ...
  3. ... plus streptozotocin or mitotane plus etoposide, doxorubicin, and cisplatin, as evidenced by the NCT00924144 phase III ... Trials of other chemotherapy ...
  4. ... Brien T, Bradburn M, et al. Vascular endothelial growth factor is a predictor of relapse and stage ... receiving cisplatin or carboplatin. Scand Audiol. 1999; 28 (3):139– ...
  5. ... intake of alcohol are less likely to experience cisplatin-induced N&V.[ 4 ] Age. ... invasion or growth in the gastrointestinal tract, liver, or central nervous ...
  6. ... ciprofloxacin was the commonest choice of antibiotic. Prophylactic growth factors – primary prophylaxis It was reported that growth factors ( ... preparation for the majority of their regimens. Prophylactic growth factors – secondary prophylaxis Growth factors were used for secondary ...
  7. ... pathways to an extent similar to tumor necrosis factor-alpha (TNF-alpha).[ 40 ] Furthermore, ... drug cisplatin .[ 5 , 27 , 34 , 41 ] All the aspects of ...
  8. NLM Digital Collections - National Library of Medicine classification : a scheme for the shelf arrangement of library ... 
    Publication: Bethesda, Md. : U.S. Dept. of Health and Human Services, Public Health Service, National Institutes of Health, National Library of Medicine ; Washington, DC : For sale by the Supt. of Docs., U.S. G.P.O., 1999
    ... QY 410 Platelet Transforming Growth Factor see Transforming Growth Factor beta ... see Cisplatin Platybasia WE 730 Platyhelminths QX 350-422 Platyrrhina ...
  9. ... tw. 10 or/7-9 11 Receptor, Epidermal Growth Factor/ use ppez 12 epidermal growth factor receptor/ use emez 13 (epidermal growth factor or egf receptor or (growth factor adj3 receptor) ...
  10. ... protein kinase inhibitor$”).ti,ab. 70 (“vascular endothelial growth factor$” adj2 inhibitor$).ti,ab. 71 “Poly(ADP-ribose) ... inhibitor$).ti,ab. 80 (“EGFR inhibitor$” or “epidermal growth factor inhibitor$” or “epidermal growth factor receptor inhibitor$”).ti, ...
first · previous · 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · next · last